Live from the NIH registry
Studies recruiting near Round Lake Beach right now
Top 25 of 466 recruiting studies, sorted by proximity — each links to its official registry page
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Aurora Cancer Care - Kenosha South — Kenosha, Wisconsin (19.4 mi)
· Sponsor: American Society of Clinical Oncology
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
AMG Libertyville - Oncology — Libertyville, Illinois (9.3 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10041, Island Lake, IL — Island Lake, Illinois (9.1 mi)
· Sponsor: Colorado Prevention Center
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Advocate Children's Hospital-Park Ridge — Park Ridge, Illinois (28.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Orchard Healthcare Research Inc. — Skokie, Illinois (29.8 mi)
· Sponsor: Regeneron Pharmaceuticals
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Niles, Illinois (28.7 mi)
· Sponsor: Daiichi Sankyo
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Phase 2
Interventional 40 participants sought
Endeavor Health Medical Group — Skokie, Illinois (29.8 mi)
· Sponsor: Incyte Corporation
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Northwestern Medicine Grayslake Outpatient Center — Grayslake, Illinois (3.1 mi)
· Sponsor: SWOG Cancer Research Network
Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth in/Near Infected Bone Cavities
Periprosthetic Joint Infections
N/A
Interventional 204 participants sought
Endeavor Health Skokie Hospital — Skokie, Illinois (29.8 mi)
· Sponsor: Elute, Inc.
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Niles, Illinois (28.7 mi)
· Sponsor: AstraZeneca
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
Midwestern Regional Medical Center — Zion, Illinois (13.5 mi)
· Sponsor: Canadian Cancer Trials Group
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Illinois Cancer Specialists — Arlington Heights, Illinois (20.7 mi)
· Sponsor: SCRI Development Innovations, LLC
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
Endevour Health — Skokie, Illinois (29.8 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Alzheimers Disease, Dementia
Phase 2, Phase 3
Interventional 280 participants sought
Advocate Lutheran General Hospital — Park Ridge, Illinois (28.2 mi)
· Sponsor: Washington University School of Medicine
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Chronic Kidney Disease
Phase 2
Interventional 465 participants sought
Endeavor Health — Skokie, Illinois (29.8 mi)
· Sponsor: Novo Nordisk A/S
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Northwestern Medicine Grayslake Outpatient Center — Grayslake, Illinois (3.1 mi)
· Sponsor: NRG Oncology
Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
Glaucoma, Open-angle, Ocular Hypertension (OHT)
Phase 4
Interventional 132 participants sought
Glaukos Investigator Site — Kenosha, Wisconsin (19.4 mi)
· Sponsor: Glaukos Corporation
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
Open Angle Glaucoma (OAG)
N/A
Interventional 165 participants sought
The Eye Centers of Racine & Kenosha — Kenosha, Wisconsin (19.4 mi)
· Sponsor: Avisi Technologies Inc.
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 500 participants sought
Local Institution - 1148 — Elgin, Illinois (25.7 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Systemic Lupus Erythematosus
Phase 3
Interventional 550 participants sought
Robert A Hozman MD SC — Skokie, Illinois (29.8 mi)
· Sponsor: Novartis Pharmaceuticals
Investigations of Reproductive Cancers in Women
Uterine Cancer
N/A
Observational 4,500 participants sought
Ob-Gyne Associates of Lake Forest, Ltd — Lake Forest, Illinois (14.8 mi)
· Sponsor: PinkDx, Inc.
Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
Cystic Fibrosis, CFTR Gene Mutation
Phase 2
Interventional 33 participants sought
The Cystic Fibrosis Institute — Northfield, Illinois (24.7 mi)
· Sponsor: Arcturus Therapeutics, Inc.
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Midwest Digestive Health & Nutrition — Des Plaines, Illinois (25.9 mi)
· Sponsor: Eli Lilly and Company
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Ulcerative Colitis, Crohn's Disease
Phase 3
Interventional 240 participants sought
Advocate Children's Hospital - Park Ridge - PIN — Park Ridge, Illinois (28.2 mi)
· Sponsor: Takeda
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
Irritability Associated With Autism Spectrum Disorder
Phase 3
Interventional 160 participants sought
Revive Research Institute — Elgin, Illinois (25.7 mi)
· Sponsor: Intra-Cellular Therapies, Inc.